NCT07136506 Gait Analysis Parameter and Upper Limb Evaluation in Control Participants
| NCT ID | NCT07136506 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Liege |
| Condition | Healthy Participants |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-24 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-09-24 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ActiControl study is a monocentric, academic, and fully remote observational study designed to build a normative, longitudinal dataset using the Syde® wearable device. The study will enroll 200 healthy volunteers across all age groups, genders, and backgrounds. Participants will be remotely recruited and followed over two years, wearing the Syde® device for 3-week periods every 6 months. All study visits, including consent, data collection, and follow-up, are conducted remotely via phone or video conferencing. The primary objectives are to collect reference data on gait and movement patterns and to assess adherence and acceptability of the device. Secondary objectives include evaluating the reliability of digital endpoints and the influence of demographic and lifestyle factors on these measures.
Eligibility Criteria
Inclusion Criteria: * Male and female of different age groups * Signed informed consent form by participant him/herself or, in case of patients \<18 years old, signed informed consent form by patient's parents or legal guardians * Able to ambulate (minimum 10 meters without help) * Participant willing and able to comply with all study procedures Exclusion Criteria: * Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the upper or lower limbs * Elite athletes (at the national level) * Pregnant women * A chronic or acute muscular, neurological, infectious, or inflammatory pathology within the 3-week period immediately prior to inclusion * An orthopedic, neuromuscular, or neurological pathology that affects the quality of the participant's walking gait * No access to unlimited internet connection or alternatively no capacity to come on-site to upload Syde data
Contact & Investigator
Laurent Servais, MD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Liege
Frequently Asked Questions
Who can join the NCT07136506 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07136506 currently recruiting?
Yes, NCT07136506 is actively recruiting participants. Contact the research team at Nicolas.Bovy@citadelle.be for enrollment information.
Where is the NCT07136506 trial being conducted?
This trial is being conducted at Liège, Belgium.
Who is sponsoring the NCT07136506 clinical trial?
NCT07136506 is sponsored by Centre Hospitalier Universitaire de Liege. The principal investigator is Laurent Servais, MD at Centre Hospitalier Universitaire de Liege. The trial plans to enroll 200 participants.